Xenoport Wins U.s. Approval For Restless Legs Treatment

XenoPort Inc. and GlaxoSmithKline Plc won U.S. approval for a new treatment for restless legs syndrome after more than a year of delays. XenoPort’s shares climbed 57 percent in extended trading after the announcement.

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News